California Institute for BioMedical Research (EIN 453682796) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2011

Legal Domicile

Principal Officer

Peter G Schultz PhD

Phone

8582421029

Tax Period

2017-10-01 to 2018-09-30

California Institute for BioMedical Research, founded in 2011, is a mid-sized nonprofit that reported $98.8M in total revenue in fiscal year 2017. Revenue surged 2314% from the prior year, signaling strong growth momentum. The organization ran a surplus of $58.4M, a strong 59% operating margin.

Mission

The California Institute for Biomedical Research (CALIBR) accelerates the translation of basic biomedical research to new medicines for unmet medical needs.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2017)

Revenue Breakdown

Contributions & Grants $22,438,747

Program Service Revenue $63,285,520

Investment Income $167,492

Other Revenue $12,905,300

TOTAL REVENUE $98,797,059

Expense Breakdown

Grants Paid $124,436

Salaries & Benefits $9,952,959

Fundraising Expenses $0

Program Expenses $35,427,676

Other Expenses $30,300,341

TOTAL EXPENSES $40,377,736

Year-over-Year Comparison

	2017	2016	Change
Revenue	$98,797,059	$4,092,975	+23.1%
Expenses	$40,377,736	$4,353,309	+8.3%
Net Income	$58,419,323	$-260,334	-225.4%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

157

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$1,996,161

Total Directors

$1,225,992

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Peter G Schultz	CEO/President & Chair	40.00	Officer Director	$285,562	$67,321	$721,397
Herbert Boyer	Board Member	1.00	Director	$0	$0	$0
Ronald Burkle	Board Member	1.00	Director	$0	$0	$0
Gerald Chan Start 32918	Board Member	1.00	Director	$0	$0	$0
John D Diekman Start 32918	Board Member	1.00	Director	$0	$0	$0
Mark Edwards	Board Member	1.00	Director	$0	$0	$0
Peter C Farrell PHD DSc	Board Member (Start 3/28/18)	1.00	Director	$0	$0	$0
Isy Goldwasser	Board Member	1.00	Director	$0	$0	$0
Benedict Gross Start 92818	Board Member	1.00	Director	$0	$0	$0
William R Hearst III	Board Member (Start 3/29/18)	1.00	Director	$0	$0	$0
Jeffery Kelly Start 92818	Board Member	1.00	Director	$0	$66,417	$439,110
Sherry Lansing Start 5718	Board Member	1.00	Director	$0	$0	$0
Ge Li Start 32918	Board Member	1.00	Director	$0	$0	$0
Claudia S Luttrell	Board Member (Start 3/29/18)	1.00	Director	$0	$0	$0
Joel S Marcus Start 32918	Board Member	1.00	Director	$0	$0	$0
John Martin Start 5718	Board Member	1.00	Director	$0	$0	$0
Mark Pearson Start 32818	Board Member	1.00	Director	$0	$0	$0
Bernard Saint-Donat PHD	Board Member (Start 3/28/18)	1.00	Director	$0	$0	$0
Paul R Schimmel End 92818	Board Member	1.00	Director	$0	$21,185	$65,485
Christopher T Walsh	Board Member	1.00	Director	$0	$0	$0
Douglas A Bingham	Secretary/EVP of Scripps Florida	1.00	Officer	$0	$60,656	$362,444
Kelly San George End 32818	CFO, CALIBR/Treasurer	40.00	Officer	$67,786	$1,443	$69,229
Jared M Machado	CFO,Scripps/Treasurer	1.00	Officer	$0	$65,619	$339,049
Matthew S Tremblay	COO,CALIBR/Secretary (End 3/28/18)	40.00	Officer	$216,426	$7,823	$389,305
Tamara L Barnas	Asst Secretary	0.00	Officer	$0	$23,393	$114,737
Leonardo Sahelijo	VP, Translational Medicine	40.00	Highest	$365,208	$22,775	$387,983
Vadim Klyushnichenko	VP of Pharm. Dev & Quality	40.00	Highest	$314,321	$28,151	$342,472
Arnab K Chatterjee	VP, Medicinal Chemistry	40.00	Highest	$234,592	$2,478	$237,070
Jing Li	VP, Program Management	40.00	Highest	$216,149	$5,431	$221,580
John A Wisler	VP, Toxicology and Pharmacokinetics	40.00	Highest	$225,104	$20,765	$245,869

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2018	$98,797,059	$40,377,736	No data	$58,419,323

California Institute for BioMedical Research